Detalhe da pesquisa
1.
Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in Women.
AIDS Behav
; 27(11): 3596-3602, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221330
2.
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
J Infect Dis
; 226(3): 510-520, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134995
3.
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial.
AIDS Behav
; 25(8): 2430-2440, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713213
4.
Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling.
J Acquir Immune Defic Syndr
; 92(2): 122-126, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184755
5.
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial.
BMJ Open
; 13(8): e076843, 2023 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640457
6.
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial.
Lancet HIV
; 10(4): e230-e243, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001964
7.
Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
J Int AIDS Soc
; 25(7): e25957, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785472
8.
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women.
BMJ Open
; 12(1): e052880, 2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992111
9.
Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan Africa.
Int J STD AIDS
; 32(7): 620-628, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752534
10.
Brief Report: Anal Intercourse, HIV-1 Risk, and Efficacy in a Trial of a Dapivirine Vaginal Ring for HIV-1 Prevention.
J Acquir Immune Defic Syndr
; 83(3): 197-201, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809308
11.
Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
AIDS
; 33(10): 1619-1622, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306167
12.
Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa.
Int Perspect Sex Reprod Health
; 45: 61-69, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859669
13.
Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Contraception
; 100(3): 214-218, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226323
14.
Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy.
J Acquir Immune Defic Syndr
; 79(5): 566-572, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383589
15.
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
J Acquir Immune Defic Syndr
; 76(2): e47-e51, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28542081